ArticleNPJ precision oncology2026

Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trial.

Ting Pu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.